19 June 2013
Keywords: betakine, tested, retinal, edema, celtrix, pharmaceuticals, begun
Article | 22 August 1994
Celtrix Pharmaceuticals has begun Phase I/II testing of its recombinant
transforming growth factor beta product BetaKine to treat retinal ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 August 1994
15 August 1994
18 June 2013
© 2013 thepharmaletter.com